# US 2021/0079459 A1 · Methods of Amplifying Nucleic Acids and Compositions and Kits for Practicing the Same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0079459 A1
- Document ID: US20210079459A1
- Status: Published application
- Kind: A1
- Application number: 16/963,365
- Filed: 2019-02-07
- Published: 2021-03-18
- Earliest claimed: 2018-05-01
- Assignees: Takara Bio USA, Inc.
- Applicants: Takara Bio USA, Inc.
- Inventors: Kazuo Tori
- Web page: https://patentgrep.com/patent/US20210079459A1

## CPC

- C12P 19/34: Polynucleotides, e.g. nucleic acids, oligoribonucleotides
- C12Q 1/6853: using modified primers or templates
- C12Q 1/6844: Nucleic acid amplification reactions
- C12Q 2521/327: RNAse, e.g. RNAseH
- C12Q 2525/191: incorporating an adaptor
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Methods of amplifying nucleic acids in a sample are provided. Aspects of the methods include: a) fragmenting nucleic acids in the sample to produce a fragmented nucleic acid sample; b) contacting the fragmented nucleic acid sample with a cDNA synthesis primer comprising a RNA origination domain under cDNA synthesis conditions to produce a product nucleic acid composition; and c) amplifying the product nucleic acid composition. Compositions and kits for use in performing the methods are also provided.

## Claims

### Claim 1

A method for amplifying nucleic acids in a sample, the method comprising:
a) contacting a fragmented nucleic acid sample comprising RNA and DNA with a cDNA synthesis primer comprising an RNA origination domain under cDNA synthesis conditions to produce a product nucleic acid composition; and
b) amplifying the product nucleic acid composition.

### Claim 2 (depends on 1)

The method of claim 1, wherein the fragmented nucleic acid sample is fragmented by a transposase, by shearing, or a combination thereof.

### Claim 3 (depends on 2)

The method of claim 2, wherein the transposase attaches adaptors to DNA in the sample during the fragmenting.

### Claim 4 (depends on 3)

The method of claim 3, wherein the adaptors comprise a DNA origination domain.

### Claim 5 (depends on 1)

The method of claim 1, wherein the cDNA synthesis conditions comprise reverse transcribing the RNA.

### Claim 6 (depends on 5)

The method of claim 5, wherein the reverse transcribing is coupled to template switching by a template switch oligonucleotide.

### Claim 7 (depends on 6)

The method of claim 6, wherein the template switch oligonucleotide comprises an RNA origination domain.

### Claim 8 (depends on 7)

The method of claim 7, wherein the RNA origination domain of the cDNA synthesis primer and the RNA origination domain of the template switch oligonucleotide differ from each other by at least one nucleotide.

### Claim 9 (depends on 7)

The method of claim 7, wherein the RNA origination domain of the cDNA synthesis primer and the RNA origination domain of the template switch oligonucleotide have the same sequence.

### Claim 10 (depends on 7)

The method of claim 7, wherein the RNA origination domain of the cDNA synthesis primer and the RNA origination domain of the template switch oligonucleotide are combined to generate a single RNA origination domain.

### Claim 11 (depends on 1)

The method of claim 1, further comprising sequencing nucleic acids of the product nucleic acid composition.

### Claim 12 (depends on 11)

The method of claim 11, wherein the method further comprises determining whether a nucleic acid of the product nucleic acid composition originated from RNA or DNA depending on the presence of the RNA origination domain.

### Claim 13 (depends on 1)

The method of claim 1, wherein the sample is from a single cell.

### Claim 14

A composition comprising:
a) a template ribonucleic acid (RNA);
b) a cDNA synthesis primer comprising a first domain that hybridizes to the template RNA and an RNA origination domain;
c) a template switch oligonucleotide comprising a 3′ hybridization domain; and
d) a product cDNA hybridized to the template RNA and the template switch oligonucleotide, each of the template RNA and template switch oligonucleotide hybridized to adjacent regions of the product cDNA.

### Claim 15

A kit comprising:
a) a cDNA synthesis primer comprising an RNA origination domain;
b) a buffer; and
c) instructions for use.

### Claim 16 (depends on 15)

The kit according to claim 15, further comprising a template switch oligonucleotide.

### Claim 17 (depends on 16)

The kit of according to claim 16, wherein the template switch oligonucleotide comprises an RNA origination domain.

### Claim 18 (depends on 17)

The kit according to claim 17, further comprising a reagent selected from the group consisting of: a polymerase, a reverse transcriptase, dNTPs, a reverse transcription buffer, a DNA polymerization buffer, and an RNase inhibitor or any combination thereof.

### Claim 19 (depends on 17)

The kit according to claim 17, further comprising a transposome comprising adaptors comprising a DNA origination domain.

### Claim 20 (depends on 14)

The composition according to claim 14, further comprising a template deoxyribonucleic acid (DNA).
